Results 181 to 190 of about 22,201 (271)

Why are we limiting access to opioid agonist therapies? [PDF]

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada, 2019
openaire   +2 more sources

The time for emergency department opioid agonist therapy is now: “A BC perspective” [PDF]

CJEM, 2019
Andrew Kestler, Jason Wale, Melissa Allan   +2 more
openaire   +2 more sources

Characterization of the Pharmacokinetics and Physiological Effects of Tapentadol in Horses

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Tapentadol is a dual mechanism analgesic utilizing both μ‐opioid receptor (MOR) agonism and norepinephrine reuptake inhibition (NRI). This study evaluated the pharmacokinetics and pharmacodynamics of tapentadol as a potential analgesic with the goal of treating pain in horses.
Annabella D. Lynch, Khursheed R. Mama, Dan S. McKemie, Phillip H. Kass, Heather K. Knych   +4 more
wiley   +1 more source

Commentary on Young et al.: Clinical guidance is required for stimulant co-prescription with opioid agonist therapy. [PDF]

Addiction
Ezard N, Siefried KJ, Clifford B.
europepmc   +1 more source

“Buprenorphine doesn't hold me”: Neurochemical afterlives of state violence and the struggle for meaning in addiction treatment

Medical Anthropology Quarterly, EarlyView.
Abstract This paper analyzes two disparate experiences of buprenorphine, a medication for opioid addiction, in California. Within the context of the U.S. War on Drugs and after decades of criminalization, buprenorphine represents a shift toward outpatient medical treatment of opioid addiction, but it has been unequally distributed and experienced ...
Textor Lauren
wiley   +1 more source

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients. [PDF]

Front Psychiatry, 2023
Mahu IT, Conrod PJ, Barrett SP, Sako A, Swansburg J, Stewart SH.   +5 more
europepmc   +1 more source

Exploring metacognitive function in patients with opioid use disorder: A pilot study

Psychology and Psychotherapy: Theory, Research and Practice, EarlyView.
Abstract Objectives Despite recognised cognitive deficits related to substance use, as well as high mortality and treatment attrition rates, metacognition has never been studied in patients with opioid use disorder (OUD) undergoing opioid maintenance treatment (OMT).
John Hanson Högberg, Björn Philips, Jonas Stålheim, Kristina Berglund   +3 more
wiley   +1 more source

Opioid Agonist Therapy Adherence Trajectories Among Commercially and Publicly Insured People Living With Hepatitis C in the United States. [PDF]

Epidemiology
Psaras C, Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ.   +7 more
europepmc   +1 more source

One in four inmates receiving methadone for opioid addiction at Mountjoy Prison.

Almost one in four inmates at Mountjoy Prison is receiving methadone for opioid addiction, new figures have revealed. The proportion is highest among inmates in the women’s prison at the Mountjoy campus, where 40 per cent of prisoners are receiving ...
McDonagh, Darragh
core  

Acute pain transfusion reaction in a patient with thalassemia: In‐depth characterization of short‐ and long‐term phenotypes

Transfusion, EarlyView.
Abstract Background Acute pain transfusion reaction (APTR) is a rare, under‐recognized condition of unknown etiology. It can cause significant distress in recipients, necessitating symptomatic management and, occasionally, hospitalization. Study Design and Methods Here, we present an APTR event in an adult subject with transfusion‐dependent thalassemia
Georgia Tzafa, Sophia Delicou, Ioanna Barla, Konstantina Theocharaki, Aggeliki Kondi, Athanassios D. Velentzas, Nikolaos Simantiris, Elli‐Anna Stylianaki, George Mpekoulis, Efthymia Pavlou, Niki Vassilaki, Ioannis V. Kostopoulos, Aikaterini Xydaki, Efrosyni Nomikou, Ioanna‐Katerina Aggeli, Nikolaos Thomaidis, Evangelos Gikas, Martina Samiotaki, Jerome Zoidakis, Constantina Politis, Marianna H. Antonelou   +20 more
wiley   +1 more source